PGDT in Patients Undergoing Kidney Transplant
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Sep 1, 2021
Trial Information
Current as of July 23, 2025
Completed
Keywords
ClinConnect Summary
To reduce perioperative complications optimal fluid management is essential in patients undergoing kidney transplantation. Heart rate, Medium Arterial Pressure (MAP), Central Venous Pressure (CVP), and urine output have been proposed in the literature to guide perioperative fluid therapy. These criteria are routinely applied in clinical practice; however these criteria have shown low sensitivity and poor predictive of postoperative complication, especially if used alone. The traditional approach in renal transplantation is the volume infusion guided whit CVP to the point of no further fluid...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \> 18 years,
- • first single- or dual-kidney transplant from a deceased donor,
- • absence of atrial fibrillation or other severe arrythmia,
- • ASA (American Society of Anesthesiologists) class III-IV,
- • presence of written expression of consent.
- Exclusion Criteria:
- • patients receiving a retransplant,
- • patients receiving a combined liver-kidney transplant,
- • patients receiving a transplant from a living donor .
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ancona, , Italy
Torino, , Italy
Patients applied
Trial Officials
Antonio Siniscalchi, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials